Dublin, Aug. 31, 2022 (GLOBE NEWSWIRE) -- The "Interventional Vascular Consumables Market Research Report: By Type, Product Type - Revenue Estimation and Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.
From an estimated $3,929.2 million in 2021, the interventional vascular consumables market revenue is predicted to grow to $5,501.7 million by 2030, at a CAGR of 3.8%.
Since interventional vascular procedures are performed on the arteries and veins, the rising incidence of heart diseases has a direct positive influence on the demand for the consumables used during these procedures.
Among all the consumables used, the demand for catheters is the highest. This is because catheters are widely used to introduce drugs and other agents through the blood vessels to the site of intervention or remove fluids from the body.
Moreover, most catheters are used only once, to protect patients from hospital-acquired infections; therefore, they need to be procured in bulk regularly.
Currently, the strongest positive impact of product launches for market players is being seen in North America. Led by the U.S., the region is home to the largest healthcare sector in the world.
Moreover, the established medical reimbursement system allows people to undergo interventional vascular and other procedures, which drives the demand for the associated consumables. Moreover, the CDC says that in the U.S., 14.2% of the population above the age of 45 years reports a stroke, coronary artery disease, or both.
The major companies in the interventional vascular consumables market are Boston Scientific Corporation, Abbott Laboratories, Medtronic plc, Terumo Corporation, Cook Medical LLC, Becton, Dickinson and Company, Merit Medical Systems Inc., Heraeus Holding GmbH, B. Braun Melsungen AG, and Johnson & Johnson.
Apart from launching new consumables, they are engaging in mergers and acquisitions and facility and geographical expansions.
Key Findings of Interventional Vascular Consumables Market Report
- Between coronary and peripheral consumables, the coronary type are used more because of the rising prevalence of coronary artery disease. As per the American College of Cardiology, disability-adjusted life years due to this condition stood at 182 million in 2019, while the number of deaths because of it numbered 9.14 million.
- A key factor driving the interventional vascular consumables market is the rising geriatric population, which has now begun preferring minimally invasive surgeries, which are quick and cost-effective, cause less pain, and have a shorter recovery period.
- Inferior vena cava (IVC) filters are expected to record a rapid increase in demand in the coming years as they filter out clots, thus preventing them from traveling through the IVC to the lungs and causing a pulmonary embolism.
- Additionally, with the increasing spending on R&D, newer, more-advanced catheters, IVF filters, and other interventional vascular consumables are making it to healthcare settings, thus enhancing the outcomes for patients.
- For instance, Merit Medical Systems Inc. launched the One-Vac evacuated drainage bottle in August 2021. It has an ergonomic handle, which allows doctors to regulate the flow and is easy to hold and remove, thus offering doctors and, ultimately, patients, more convenience.
- Thus, product launch has become one of the strongest tools for interventional vascular consumables market players to strengthen their hold and get ahead of their competitors.
Key Topics Covered:
Chapter 1. Research Background
Chapter 2. Research Methodology
Chapter 3. Executive Summary
Chapter 4. Voice of Industry Experts/Kols
Chapter 5. Market Indicators
5.1 Increasing Geriatric Population
Chapter 6. Definition of Market Segments
6.1 by Type
6.1.1 Coronary
6.1.2 Peripheral
6.2 by Product Type
6.2.1 Catheter
6.2.2 Guidewire
6.2.3 Embolic Protection Device
6.2.4 Ivc Filter
6.2.5 Sheath
6.2.6 Vascular Closure System
6.2.7 Vascular Patch
6.2.8 Vascular Plug
6.2.9 Others
Chapter 7. Industry Outlook
7.1 Market Dynamics
7.1.1 Trends
7.1.1.1 Mergers and Acquisitions
7.1.1.2 Product Launches
7.1.2 Drivers
7.1.2.1 High Healthcare Expenditure and Early Adoption of Interventional Radiology Procedures
7.1.2.2 Increasing Demand for Vascular Interventional Procedures Among Geriatric Population
7.1.2.3 Strong Interventional Vascular Consumables Supply Chain
7.1.3 Impact Analysis of Drivers on Market Forecast
7.1.4 Restraints
7.1.4.1 High Pricing and Complex Manufacturing
7.1.5 Impact Analysis of Restraints on Market Forecast
7.2 Impact of Covid-19
7.3 Porter's Five Forces Analysis
Chapter 8. Global Market Size and Forecast
8.1 Overview
8.2 Market Revenue, by Type (2015-2030)
8.3 Market Revenue, By, Product Type (2015-2030)
8.4 Market Revenue, by Region (2015-2030)
Companies Mentioned
- Hugo Kern Und Liebers GmbH & Co. Kg
- Integer Holdings Corporation
- Hexacath
- Eurocor Tech GmbH
- Rex Medical L.P.
- Artventive Medical Group Inc.
- Balton Sp. Z O. O.
- Cardiva Medical Inc.
- Medtronic plc
- B. Braun Melsungen AG
- Becton, Dickinson and Company
- Biosensors International Group Ltd.
- Abbott Laboratories
- Johnson & Johnson
- Confluent Medical Technologies
- Heraeus Holdings GmbH
- Lemaitre Vascular Inc.
- Prodimed
- Galt Medical Corp.
- Vygon Sa
- Terumo Corporation
- Merit Medical Systems Inc.
- Argon Medical Devices Inc.
- Cardinal Health Inc.
- Boston Scientific Corporation
- Cook Medical LLC
For more information about this report visit https://www.researchandmarkets.com/r/ti4olm
Attachment
